Pathological Importance of the Endothelin-1/ET(B) Receptor System on Vascular Diseases

Area of Science:

• Cardiovascular Research
• Pharmacology
• Vascular Biology

Background:

• The endothelin (ET)-1/ET receptor system is implicated in vascular diseases like atherosclerosis and restenosis.
• The precise roles of ET receptor subtypes, particularly ET(B), in vascular pathologies remain incompletely understood.
• The therapeutic potential of ET receptor antagonists requires further elucidation regarding subtype selectivity and sex-specific effects.

Purpose of the Study:

• To investigate the functional roles of ET receptor subtypes in vascular disease development and remodeling.
• To evaluate the therapeutic efficacy of selective ET(A) and ET(B) receptor antagonists versus nonselective antagonists.
• To explore the contribution of ET receptor systems to sex differences in vascular disease severity.

Main Methods:

• Selective and nonselective ET receptor antagonists were assessed in models of vascular injury and disease.
• Neointimal formation and vascular remodeling were quantified to evaluate therapeutic effects.
• Sex-specific responses to ET receptor antagonism were analyzed.

Main Results:

• Selective ET(B) receptor inhibition exacerbated neointimal formation after vascular injury.
• No significant difference in therapeutic effect was observed between nonselective ET(A)/ET(B) and selective ET(A) antagonists.
• ET receptor systems were found to contribute to sex differences in vascular disease severity.

Conclusions:

• Antagonism of the ET(A) receptor is crucial for suppressing vascular remodeling, independent of ET(B) receptor activity.
• Selective ET(B) receptor antagonism can be detrimental, worsening vascular remodeling.
• The efficacy of ET receptor antagonists in vascular diseases may vary between sexes, necessitating further investigation.